Search results for “Niemann–Pick disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 130 patents, we discovered top 27 key players by total patent application. Genzyme Corp., Takeda Pharmaceutical Co., Ltd., reMYND NV are dominant in this area. They take 60.00% of the total patent filing.
Genzyme Corp.
Massachusetts, United States
Patent: 42
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 14
reMYND NV
Vlaams-Brabant, Belgium
Patent: 13
Centogene AG
Mecklenburg-Vorpommern, Germany
Patent: 12
Synaptogenix, Inc.
New York, United States
Patent: 5
Kowa Co., Ltd.
Aichi-ken, Japan
Patent: 3
Orphazyme A/S
Hovedstaden, Denmark
Patent: 3
Idorsia Pharmaceuticals Ltd.
Switzerland
Patent: 3
Nihon Shokuhin Kako Co., Ltd.
Tokyo-to, Japan
Patent: 2
The University of Georgia Research Foundation, Inc.
Georgia, United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Stridebio, Inc.
North Carolina, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 21 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Genzyme Corp., Orphazyme A/S, Icahn School of Medicine at Mount Sinai take 52.38% of patent filing during this period.
Genzyme Corp.
Massachusetts, United States
Patent: 5
Orphazyme A/S
Hovedstaden, Denmark
Patent: 3
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 3
Consejo Superior de Investigaciones Científicas
Madrid, Spain
Patent: 2
KemPharm Denmark A/S
Denmark
Patent: 2
Centogene AG
Mecklenburg-Vorpommern, Germany
Patent: 1
Kashiv Pharma, LLC
New Jersey, United States
Patent: 1
Retrotope, Inc.
California, United States
Patent: 1
United States of America
United States
Patent: 1
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 21 patents in last 5 years, we discover 6 new entrants. Orphazyme A/S, KemPharm Denmark A/S, Kashiv Pharma, LLC are the most active new entrants in this area.
Orphazyme A/S
Hovedstaden, Denmark
Patent: 3
KemPharm Denmark A/S
Denmark
Patent: 2
Kashiv Pharma, LLC
New Jersey, United States
Patent: 1
Retrotope, Inc.
California, United States
Patent: 1
STARTUP
Stridebio, Inc.
North Carolina, United States
Patent: 1
Kyoto Pharmaceutical Industries Ltd.
Kyoto-fu, Japan
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 51 patents, we discovered top 6 universities and scientific research institutions by total patent application. Icahn School of Medicine at Mount Sinai, Washington University in St. Louis, Consejo Superior de Investigaciones Científicas are dominant in this area. They take 109.80% of the total patent filing.
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 34
Washington University in St. Louis
Missouri, United States
Patent: 3
Consejo Superior de Investigaciones Científicas
Madrid, Spain
Patent: 3
Kumamoto University
Kumamoto-ken, Japan
Patent: 3
University of Barcelona
Spain
Patent: 1
Pukyong National University
South Korea
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: